Drugmakers struggle to meet demand for antidepressant Zoloft amid COVID-19 esagonowsky Tue, 06/02/2020 – 09:18 More: Drugmakers struggle to meet demand for antidepressant Zoloft amid COVID-19 Source: fierce
read moreRinvoq is a selective and reversible JAK inhibitor being studied in several immune-mediated inflammatory diseases More: AbbVie files Rinvoq for psoriatic arthritis Source: News
read moreThe company is now mulling over its future, which might include sale of the business, restructure, or dissolving and liquidating assets More: Iterum hit by failure of anti-infective sulopenem Source: News
read moreNew Brilinta indication expands treatment to high-risk coronary patients without a history of stroke or heart attack More: New US approval for AZ' Brilinta Source: News
read moreThe funds will enable researchers to investigate the science around the trial, including why coronavirus affects some people more than others More: PIONEER COVID-19 trial wins funding injection from LifeArc Source: News
read more2.1 million people are waiting for breast, bowel or cervical screening More: Coronavirus bottleneck leaves 2m waiting for cancer care Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals